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Abstract The effect of three Hebridean brown seaweeds on
lipase activity was assessed using a turbidimetric lipase activ-
ity assay and an in vitro simulation of the upper digestive tract.
The preparations of Ascophyllum nodosum, Fucus
vesiculosus, and Pelvetia canaliculatawere tested; whole sea-
weed homogenate, sodium carbonate extract, and ethanol ex-
tracts (pellet and supernatant were tested separately). All ex-
tracts showed significant inhibition of lipase, suggesting mul-
tiple bioactive agents, potentially including alginates,
fucoidans, and polyphenols. Whole homogenate extract of
F. vesiculosus was the most potent inhibitor of Lipase
(IC50 = 0.119 mg mL-1), followed by ethanol supernatant
(IC50 = 0.159 mg mL-1) while ethanol pellet and sodium
carbonate extract showed relatively weaker inhibition
(IC50 = 0.360 mg mL-1 and IC50 = 0.969 mg mL-1
respectively). For A. nodosum and P. canaliculata, strongest
inhibition occurred with ethanol pellet (IC50=0.238 and
0.228 mg mL−1, respectively). These inhibitory effects were
validated in a model gut system. The data presented herein
suggests the use of seaweed as a potential weight management
tool is deserving of further investigation.
Keywords Lipase . Obesity . Fat digestion . Inhibition .
Alginate . Polyphenol . Ascophyllum nodosum . Fucus
vesiculosus .Pelvetia canaliculata
Introduction
Excess fat storage and consumption of high energy and high fat
diets are associated with an array of health complications in-
cluding increased morbidity (Bellanger and Bray 2005) and
comorbidities including cardiovascular disease (Logue et al.
2011; Nanchahal et al. 2005), Type 2 diabetes (Garg et al.
2014), cancers of the gastrointestinal tract and kidney (Calle
et al. 2003; Fujihara et al. 2012; Garg et al. 2014), metabolic
syndrome (Fujihara et al. 2012), and osteoarthritis (Tabassum
and Batty 2013). Finding effective treatments and interventions
for obesity and associated diseases is therefore paramount.
The inhibition of the digestion and absorption of dietary fat
has been demonstrated to be an effective treatment for obesity,
as seen with the pancreatic lipase inhibitor Orlistat (Lucas and
Kaplan-Machlis 2001). However, side effects including steat-
orrhea and incontinence can make it an unpleasant treatment
for the patient and reduce compliance (Padwal and Majumdar
2007). There is therefore a drive to discover and characterise
novel l ipase inhibitors with reduced side effects
(Balasubramaniam et al. 2013).
Brown seaweeds (Phaeophyta) are a rich source of bioac-
tive polysaccharides (including alginate, fucoidan, and lami-
narin) and polyphenols (including phenolic acids, flavonoids,
stilbenes, and lignans (O’Sullivan et al. 2010; Kim et al.
2014). There is evidence to suggest that these bioactive com-
pounds may be potential modulators of enzyme activity. Al-
ginate has been shown to inhibit pepsin (Rogalska et al. 1990)
and pancreatic lipase (Wilcox et al. 2014) in vitro, where in-
hibition is dependent upon the frequency of mannuronate and
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guluronate residues in the binary copolymer (Wilcox et al.
2014). A number of studies have demonstrated in vitro inhi-
bition of α-amylase and α-glucosidase by extracts of the
brown seaweeds Ascophyllum nodosum and Fucus
vesiculosus (Nwosu et al. 2011; Roy et al. 2011; Zhang et al.
2006a; Apostolidis and Lee 2010). Furthermore, polyphenol
rich plant extracts from tea and soft fruits (e.g., blueberries and
raspberries) have demonstrated inhibition of pancreatic lipase
(Sergent et al. 2012). Brown seaweeds including the species
A. nodosum, F. vesiculosus and Pelvetia canaliculata have
demonstrated high antioxidant activity (Wang et al. 2009;
O’Sullivana et al. 2011; Nwosu et al. 2011; Apostolidis and
Lee 2010) which is attributed to their high polyphenol content.
Edible seaweeds (macroalgae) are common components of
diets throughout the world (Brownlee et al. 2012). In the UK,
seaweeds are seen as an underutilised resource despite being
abundantly available, sustainably harvested, and already in use
in the UK food industry. The brown seaweeds studied herein,
A. nodosum, F. vesiculosus, and P. canaliculata, are predomi-
nantly found on the coastlines of Ireland, Scotland, Norway,
Iceland, and Canada and are used by UK food producers as a
salt replacer. The aim of this paper is therefore to investigate the
effects of these three species of Hebridean seaweed on lipase
activity. Whole seaweed and crude seaweed extracts are tested
in an in vitro system and in an artificial model gut system to
assess their potential to inhibit fat digestion in the diet.
Materials and methods
All reagents (unless otherwise stated) were purchased from
Sigma-Aldrich (USA). The three species of seaweeds were
provided in dried, powdered form by Seagreens Ltd.
(Handford Way, West Sussex, UK). A. nodosum ,
P. canaliculata, and F. vesiculosus are brown seaweeds which
are currently being harvested for human consumption in the
Outer Hebrides on the west coast of Scotland. To preserve the
quality of the seaweed, the drying process is completed at a
low temperature, within 12–24 h of being cut.
Sample preparation
Four extractions of each seaweed were prepared from dried
powder as described in Table 1.
Pancreatic lipase inhibition assay
Lipase activity was assayed using a turbidimetric method with
minor modifications (Balasubramaniam et al. 2013; Vogel and
Zieve 1963). Buffer diluent was made up of 0.033M citric acid,
0.343 M KOH, 0.033 M H3PO4, 0.033 M H3BO3, and 0.35 %
bile acid (Taurodeoxycholate or Deoxycholic acid Na salt) ad-
justed to a pH of 7.5 using HCl. Substrate solutions containing
seaweed extracts were made up of 5 mg mL−1 seaweed and re-
homogenised for a further 2 min, then diluted using substrate
solution to the following concentrations: 5, 2.5, 1.25, 0.5, 0.25,
0.125, 0.05, 0.0125, 0.005, and 0.0025 mg mL−1. Sample dose
concentrations were based on the previous investigations of
similar compounds (Balasubramaniam et al. 2013; Wilcox
et al. 2014). The substrate solution was used within 6 h of
preparation. The enzyme solution contained 1 mg mL−1 lipase
and 15 μg mL−1 co-lipase in buffer diluent. Samples were in-
cubated at 37 °C for 10 min and 200 μL of substrate solution
was transferred to 10 μL lipase or buffer solution. Eight read-
ings (5 min intervals) using a BioTek EL808 96-well plate spec-
trophotometer were taken at 405 nm (37 °C) Tables 2 and 3.
Porcine pancreatic lipase (at a final concentration of
0.048 mg mL−1) was used as a control and represents 100 %
lipase activity, and inhibition is shown as a percentage of
control lipase activity. The pancreatic lipase inhibitor Orlistat
Table 1 The four extraction methods used to isolate bioactive compounds from seaweeds
Seaweed fraction Method
Seaweed homogenate Samples were homogenised in the protocol buffer for 30 min at the required
concentration (5 mg mL−1) and filtered through glass wool before use.
Ethanol extraction—Supernatant Alcohol extracts were prepared by homogenising the sample in ethanol at 100 mg mL−1
for 30 min. The sample was centrifuged at 3000 rpm for 10 min at 20 °C. The supernatant
was then poured off and evaporated down to give a supernatant solid.
Ethanol extraction—Pellet Alcohol extracts were prepared by homogenising the sample in ethanol at 100 mg mL−1
for 30 min. The sample was centrifuged at 3000 rpm for 10 min at 20 °C. The supernatant
was then poured off and the pellet dried to give a fine powder.
Sodium carbonate extract 3 g of dried seaweed sample was mixed overnight in 0.2 M HCl. Ninety milliliters of deionised
water (dH2O) were added to the sediment (the compounds insoluble in acid) and left
to mix overnight. This solution was centrifuged at 5000 rpm for 5 min at 4 °C. Sixty
milliliters 1 M Na2CO3 were added to the pellet and stirred at 70 °C for 3 h. The solution
was filtered through glass wool overnight. The filtered solution was then centrifuged
at 10,000 rpm for 20 min at 4 °C. The supernatant was exhaustively dialyzed at 4 °C and
freeze dried to give a white, spongy, and fibrous extract.
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(at a final concentration of 0.24 mg mL−1, based on the pre-
vious investigations (Wilcox et al. 2014)) was used as a pos-
itive control giving 100 % inhibition.
The change in absorbance from time point zero was calcu-
lated for each substrate solution:
Δ Absorbance ¼ Absorbance T 0 – Absorbance Tx
Percentage of lipase activity:
% activity relative to the substrate control at Tx
¼ Δ Absorbance sample
Δ Absorbance control
 100
Synthetic gut simulation
Digestion of an olive oil substrate was assayed in a model gut
system. The system was set up as described in Houghton et al.
(2014), and samples were collected and precipitated in 10 %
trichloroacetic acid to stop enzyme activity and fat digestion
was assayed using the Zenbio Glycerol Analysis kit as per
instructions (Zenbio, Durham, USA) (Houghton et al. 2014).
Procedure Salivary Phase—At t=−10, samples and controls
were prepared in 5 mL artificial saliva and added to 5 mL dH2O
under stirring for 10 min on rollers. Gastric Phase—At t=0,
salivary preparations were added to a resting reservoir of
50 mL synthetic gastric juice (pre-incubated to 37 °C). The
remaining gastric juice was added via a Watson Marlow peri-
staltic pump (rate=0.5 mL min−1). Gastric diluent is prepared
prior to assay at t=20 to avoid pepsin autodigestion. Pancreatic
Phase—25 mL porcine bile was added at t=60 and the
pumping of synthetic gastric juicewas stopped, filtered synthetic
pancreatic juice was then pumped in at a rate of 0.5 mL−1. The
small-intestinal phase was continued until t=180. Samples of
1 mL were taken at t=0, 5, 10, 15, 30, 45, 60, 60b, 65, 70, 75,
90, 105, 120, 150, and 180. t=60b represents a second sample at
t=60 after the addition of fresh porcine bile; the removal of
sample volume was corrected for in calculations. Samples were
immediately mixed 2:1 with 10 % w/v trichloroacetic acid to
stop enzyme activity and stored at 4 °C overnight to allow for
precipitation, centrifuged at 10,000 r.p.m. for 10 min at room
temperature, and supernatant was then analysed (Alfred andRao
1971; Mossner et al. 1989; Montalto and Bensadoun 1993).
Glycerol analysis Fat digestion was assayed by quantifying
free glycerol released from 1 g of olive oil substrate using the
Zenbio Glycerol Analysis Kit (Zenbio, USA) (Zenbio 2010). A
glycerol standard curve was prepared. Five microliters of each
sample were plated out, and 40 μL of glycerol reagent A was
added to all wells and incubated for 30 min. Absorbance was
measured at 540 nm. A background control was prepared with
no substrate, and extract controls were prepared with extract and
no substrate.
Assessing the polyphenol content
An in vitro digestion procedure was based on a previousmeth-
od developed by (Aura et al. 1999). The total phenolic content
(TPC) of the extracts was determined using Folin-Ciocalteu
reagent following a previous method (Zhang et al. 2006b).
The assay was carried out on a 96-well microplate using gallic
acid as the standard. Phenolic levels are expressed as a gallic
acid equivalent, which is used as a common reference com-
pound (Pourmorad et al. 2006).
Results
Pancreatic lipase inhibition assay
Three species of seaweed (a) A. nodosum, (b) F. vesiculosus,
and (c) P. canaliculata were tested and four preparations of
seaweed were used; whole seaweed homogenate (Fig. 1a–c),
Table 2 IC50 values for extract
preparations of the seaweeds Extract IC50 (mg mL
−1)
Ascophyllum nodosum Fucus vesiculosus Pelvetia canaliculata
Homogenate 0.748 0.119 0.379
Ethanol pellet 0.238 0.360 0.228
Ethanol supernatant 1.932 0.159 1.822
Sodium carbonate 2.098 0.969 0.789
Table 3 Total Polyphenol content released from seaweed extracts
during enzymatic digestion at 10 and 70 min (mg GAE g−1 dry weight)
All values are means of triplicate assays±SE.
Seaweed source In vitro digestion stage
10 min 70 min
Ascophyllum nodosum 11.0±0.5a 34.9±0.5b
Fucus vesiculosus 28.9±0.4e 61.3±1.9f
Pelvetia canaliculata 19.6±0.3c 53.2±0.7d
At every time-point, significant differences were shown between all sam-
ples as indicated in table (different superscript letters indicate statistical
difference)
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Fig. 1 a–c Inhibition of pancreatic lipase activity by whole seaweed
homogenate of three seaweeds; a A. nodosum, b F. vesiculosus, and c
P. canaliculata. Data are represented as a percentage change in turbidity
relative to the positive control (100 %). The data represent mean values±
SD of at least n=4. *p<0.05, **p<0.001
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Fig. 2 a–c Inhibition of pancreatic lipase activity by ethanol extract—
pellet preparation of three seaweeds; a A. nodosum, b F. vesiculosus, and
c P. canaliculata. Data are represented as a percentage change in turbidity
relative to the positive control (100 %). The data represent mean values±
SD of at least n=4. *p<0.05, **p<0.001
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ethanol extraction—pellet (Fig. 2a–c), ethanol extraction—
supernatant (Fig. 3a–c), and sodium carbonate extract
(Fig. 4a–c).
Figure 1a shows the dose response inhibition of lipase ac-
tivity by A. nodosum homogenate. Significant inhibitions
(p<0.001) are observed at 5, 2.5, and 1.25 mg mL−1. At 5
and 2.5 mg mL−1, lipase activity was reduced to less than
10 % of control, comparable to that seen with the Orlistat
positive inhibition control. A significant inhibition of 68 %
was observed at 1.25 mg mL−1 (p<0.001). The IC50 of the
A. nodosum homogenate was 0.748 mg mL−1, indicating that
0.748 mg mL−1 of A. nodosum homogenate was required to
reduce the activity of 0.048 mg mL−1 lipase by half. Non-
significant activations were observed at concentrations of
0.125 mg mL−1 and below.
Figure 1b shows near complete inhibition of lipase activity
by F. vesiculosus homogenate at 5 mg mL−1 (p<0.001). At
1.25 and 2.5 mgmL−1 extracts reduced activity to below 10%
of control (p<0.001), 75 % inhibition was observed at
0.25 mg mL−1 (p<0.0001), and at 0.125 mg mL−1 activity
was reduced to below 50 % of control (p<0.001). The IC50
of the homogenate was 0.119 mg mL−1, making it the most
potent of all the seaweed extracts tested (Table 3).
Figure 1c shows inhibition of lipase activity by
P. canaliculata homogenate at 5, 2.5, and 1.25 mg mL−1 of
82, 68, and 60 %, respectively, compared with control. The
IC50 of the Pelvetia homogenate was 0.379 mg mL
−1 (Table 3).
The ethanol extraction pellet comprises of all of the compo-
nents of seaweed insoluble in ethanol, and with all three sea-
weed samples, significant inhibition was observed, with IC50
values of 0.228, 0.238, and 0.360 mg mL−1 for P. canaliculata,
A. nodosum, and F. vesiculosus, respectively (p<0.05).
The pellet remaining after ethanol extraction of A. nodosum
achieved significant inhibition of greater than 75 % at 5, 2.5, and
1.25 mg mL−1 (p<0.05) (Fig. 2a). The pellet extracts of
F. vesiculosus andP. canaliculata achieved inhibitions higher than
60 % only at 5 and 2.5 mg mL−1 (Fig.2b, c), yet all three had
similar dose response profiles and therefore similar IC50 values.
According to the IC50 values calculated, the whole seaweed
homogenate of F. vesiculosus was more potent than the etha-
nol extract pellet. Across the three seaweed samples tested, the
ethanol extract pellets of P. canaliculata and A. nodosumwere
the most potent extracts of those seaweeds confirming that the
ethanol insoluble fraction of the seaweeds has significant anti-
lipase activity (p<0.05).
The ethanol supernatant of all three seaweeds showed po-
tent inhibition of lipase activity at the higher concentrations
(Fig. 3). At 5 mg mL−1, F. vesiculosus extract completely
inhibited lipase activity, and at the same concentration,
A. nodosum and P. canaliculata showed inhibition of lipase
greater than 80 % of control. A. nodosum and P. canaliculata
extracts showed similar inhibition profiles, with IC50 values of
1.932 and 1.822 mgmL−1, respectively. The ethanol extract of
F. vesiculosus, however, demonstrated much more potent in-
hibition of lipase, with significant inhibition observed at all
C
on
tr
ol
O
rli
st
at 5 2.
5
1.
25 0.
5
0.
25
0.
12
5
0.
05
0.
02
5
0.
01
25
0.
00
5
0
25
50
75
100
125
150
P
er
ce
nt
ag
e 
Li
pa
se
 A
ct
iv
ity
 (
%
)
** **
**
(a)
(b)
(c)
C
on
tr
ol
O
rli
st
at 5 2.
5
1.
25 0.
5
0.
25
0.
12
5
0.
05
0.
02
5
0.
01
25
-50
0
50
100
150
200
P
er
ce
nt
ag
e 
Li
pa
se
 A
ct
iv
ity
 (
%
)
**
**
*
C
on
tr
ol
O
rli
st
at 5 2.
5
1.
25 0.
5
0.
25
0.
12
5
0.
05
0.
02
5
0.
01
25
0.
00
5
-50
-25
0
25
50
75
100
125
** **
**
*
** ** **
P
er
ce
nt
ag
e 
Li
pa
se
 A
ct
iv
ity
 (
%
)
**
Concentration of Sample (mg mL-1)
Concentration of Sample (mg mL-1)
Concentration of Sample (mg mL-1)
Fig. 3 a–c Inhibition of pancreatic lipase activity by ethanol extract—
supernatent of three seaweeds; a A. nodosum, b F. vesiculosus, and c
P. canaliculata. Data are represented as a percentage change in turbidity
relative to the positive control (100 %). The data represent mean values±
SD of at least n=4. *p<0.05, **p<0.001
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tested concentrations between 0.05 and 5 mg mL−1 and an
IC50 value of 0.159, an order of magnitude lower than the
other two seaweed samples.
The sodium carbonate extracts of the seaweeds showed
significant inhibition of lipase activity (Fig. 4), however, while
P. canaliculata and A. nodosum completely inhibited lipase
activity at 5 mg mL−1, the sodium carbonate extract of
F. vesiculosus only yielded a 48 % inhibition. The sodium
carbonate extract would be expected to contain mainly algi-
nate, which has previously been shown to be a potent lipase
inhibitor.
All of the samples and extracts tested showed a dose re-
sponsive inhibitory effect on pancreatic lipase compared with
the control, and the IC50 values are summarised in Fig. 3.
Gut-like conditions to assess the inhibitory potential
of F. vesiculosus
F. vesiculosus was selected for testing in a synthetic gastroin-
testinal simulation as it demonstrated the highest inhibition
(with whole homogenate) and the most consistent levels of
inhibition across other sample extracts. Homogenate and pel-
let extracts were tested at 500 mg and supernatant at 250 mg.
Sodium carbonate extract was not tested as there were insuf-
ficient amounts of raw seaweed to produce enough extract for
testing.
Orlistat significantly reduced fat digestion by 77, 73, and
71 % compared with the substrate control at 120, 150, and
180 min, respectively (p<0.0001) (Fig. 5). Only the homoge-
nate and the ethanol supernatant demonstrated reduced fat
digestion in this assay, reducing the production of free glycer-
ol significantly during the small intestinal phase of the model
gut system. At 500 mg, the homogenate extract (Fig. 5a) dem-
onstrated a reduction of glycerol release from 120 min on-
wards. In the presence of 500 mg homogenate, the concentra-
tion of glycerol in the model gut solution was 130 μM
(p<0.05), 155 μM (p<0.0005), and 171 μM (p<0.05) at
120, 150, and 180 min, respectively, indicating reductions of
33, 38, and 28 % compared with the control.
The ethanol supernatant fraction (Fig. 5b) demonstrated the
strongest inhibition when tested in the model gut system. Two
hundred and fifty milligrams of the supernatant extract signif-
icantly reduced fat digestion from 120min onwards during the
small intestinal phase of digestion. At t=120, the free glycerol
concentration was reduced by 76 % compared with the sub-
strate control (46.33 and 190.4 μM for extract and control,
respectively; p=0.001). At t=150 min, free glycerol concen-
tration was reduced by 60 % (p<0.0001) compared with the
substrate control and at t=180 min by 54 % (p<0.0001). The-
se results indicate that the bioactive compounds in the super-
natant fraction hold strong potential as pancreatic lipase inhib-
itors, this differs from IC50 data derived from the plate assay in
Fig. 3a–c, where the homogenate was more effective than the
supernatant fraction. No significant changes in glycerol re-
lease were observed with the 500 mg pellet sample (Fig. 5c).
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Fig. 4 a–c Inhibition of pancreatic lipase activity by alkaline extraction
of three seaweeds; a A. nodosum, b F. vesiculosus, and c P. canaliculata.
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Assessment of total polyphenol content
The presence of polyphenols was detected in all of the sea-
weed samples tested, and the TPC released from the extracts
increased over the course of an in vitro digestion procedure
(Fig. 6). For all species, there was a significant and substantial
increase in TPC release between 10 and 70 min. All values
differed significantly from the other species at each stage of
the digestion (Table 4). The TPC (mg GAE g−1 dry weight)
release from extracts during the in vitro enzymatic digestion
was in the order of F. vesiculosus>P. canaliculata>A.
nodosum.
Discussion
Seaweed extracts contain multiple uncharacterized com-
pounds which have bioactive potential. These compounds
may provide diverse health benefits through pharmacological
action. Their bioactivity includes acting as an anti-
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Fig. 5 Free glycerol released
from olive oil substrate during
180 min of simulated digestion in
the presence of F. vesiculosus
extracts. a Homogenate extract at
500 mg, b ethanol supernatant
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inflammatory, antioxidant, and as a potential prebiotic
(O’Sullivan et al. 2010) and seaweed isolates have previously
shown inhibition of digestive enzymes (Lordan et al. 2013).
The brown seaweeds investigated in this study,A. nodosum,
F. vesiculosus, and P. canaliculata, contain bioactive biopoly-
mers including alginate, fucoidan, and laminarin, as well as
non-polysaccharide bioactive compounds such as polyphe-
nols (O’Sullivan et al. 2010; Kim et al. 2014). The abundance
of polysaccharides present is dependent on harvesting season
(Rioux et al. 2007). Thismeans that seaweed extracts will vary
somewhat in composition and produce different yields of
polysaccharide.
Four extractions of each seaweed were prepared from dried
powder as described in Table 1. The seaweed homogenate
contained all compounds present in each of the seaweeds.
The ethanol extraction separated the ethanol soluble and in-
soluble compounds (supernatant and pellet, respectively). The
ethanol supernatant would be expected to contain carotenoids,
polyphenols such as phlorotannins and the ethanol pellet
would be expected to contain the ethanol insoluble carbohy-
drates including alginate and fucoidan (Warkoyo and Saati
2011; Samee et al. 2009). The sodium carbonate extract is
expected to be predominantly alginate (Fenoradosoa et al.
2009). The whole homogenate extract of F. vesiculosus was
the most potent lipase inhibitor in the lipase activity assay, and
supernatant portions of the ethanol extract all showed potent
inhibition with the sodium carbonate extract showing weaker
inhibition. These data suggest that both ethanol soluble and
insoluble components of this seaweed have significant potent
inhibitory effect which, in combination in the whole homog-
enate sample, acts to give an additive effect of increased inhi-
bition. While the homogenate appeared the most potent lipase
inhibitor in the lipase activity assay, the supernatant fraction
showed the largest reduction in fat digestion in the physiolog-
ically relevant gut model. This may be because bioactive com-
pounds present in the homogenate had greater affinity for
other digestive enzymes present in the model gut system such
as pepsin, amylase, and trypsin, which could potentially re-
duce the inhibition of lipase by the homogenate in the gut
model (Chater 2014). No significant changes were observed
with pellet sample, this may be due to large variation in the
data or that the amount of pellet used was too small to produce
an effect (given that the pellet IC50 was larger than the super-
natant and homogenate).
For A. nodosum, moderate inhibition was observed with
the homogenate, strong inhibition with the pellet extract and
only weak inhibition with the supernatant and sodium carbon-
ate extracts. This suggests that in this seaweed, non-alginate
ethanol insoluble components have potent inhibitory effects
on lipase activity. This pattern was also observed for
P. canaliculata, where the pellet extract displayed strong inhi-
bition, the homogenate moderate inhibition and the superna-
tant and alkaline fractions lower levels of inhibition.
The mechanism of pancreatic lipase inhibition by these
seaweed extracts is unknown, however, the mechanisms of
action have been proposed for other pancreatic lipase inhibi-
tors. For example, physical blocking of the interaction be-
tween TAG (in oil phase) and the enzyme (in aqueous phase)
at the water–oil interface preventing lipase accessing the sub-
strate (Wilcox et al. 2014; Winkler et al. 1990). Binding of
substrate and inhibitor, preventing substrate entering the ac-
tive site of lipase, may be possible. A mechanism similar to
that observed for the inhibition of lipase by pectin may occur,
where the Ser-Asp-His/Glu catalytic triad of the lipase active
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Table 4 Relationship between TPC and lipase inhibition
Extract Total phenolic content (TPC) mg−1 GAE
dry weight after 70 min of in vitro digestion
IC50 (mg mL
−1)
Ethanol
pellet
Sodium
carbonate
Whole Seaweed
homogenate
Ethanol
supernatant
Ascophyllum nodosum 34.9 0.238 2.098 0.748 1.932
Fucus vesiculosus 61.3 0.36 0.969 0.119 0.159
Pelvetia canaliculata 53.2 0.228 0.789 0.379 1.822
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site (Winkler et al. 1990; Emmerich et al. 1992; Kumar and
Chauhan 2010) undergoes a conformational change after pro-
tonation of histidine or serine residues by –COOH groups of
pectin (Kumar and Chauhan 2010). As such, the enzyme-
substrate complex does not form, protonation of the first glyc-
erol carbon is prevented, and cleavage of the glycerol-fatty
acid sn-1 ester bond cannot occur. It is possible that seaweed
components including alginate and polyphenols act in a sim-
ilar manner to inhibit lipase activity. As discussed by Wilcox
et al. (2014), carboxyl groups in G-block structures of alginate
are similarly oriented to the backbone of pectin molecules and
it is therefore possible that they interact with the active site via
a similar mechanism (Wilcox et al. 2014). The low inhibition
observed in the lipase activity assay for the sodium carbonate
extracts in this study (relative to other extracts) may be due to
alginate gelation causing reduced interaction between alginate
and the enzyme/substrate (De Boisseson et al. 2004). Previous
studies indicate that the G:M ratio (unknown in these extracts)
is a determining factor for alginate inhibition of pancreatic
lipase, where alginate bioactivity is dependent on sugar resi-
due composition and molecular weight (Wilcox et al. 2014). It
may therefore be that the alginate extracted from the three
species of seaweed has a low G:M ratio. Characterising the
G:M ratio of the three seaweed alginates would clarify this
observation.
Fucoidan, another fibrous biopolymer present in
F. vesiculosus, is comprised of sulfated fucose residues along-
side other monosaccharides (Li et al. 2008). Fucoidans pre-
cipitate in alcohol and were present in the ethanol pellet frac-
tion (and homogenate). It was not possible to detail any inhi-
bition of pancreatic lipase by fucoidan alone because the pellet
fraction contained multiple compounds. Despite this, recent
evidence suggests that fucoidan from F. vesiculosus can inhib-
it α-glucosidase by 80 % depending upon season of harvest,
with seaweed harvested in autumn yielding the highest levels
of inhibition (Kim et al. 2014).
Alcohol extracts of F. vesiculosus are reported to contain
approximately 23 % polyphenols (Zhang et al. 2006b). Poly-
phenols can be consumed at levels up to 1 g day−1 in the diet
(Scalbert et al. 2005). The inhibition by the supernatant frac-
tion may be due to its polyphenol content, given their previ-
ously demonstrated ability to inhibit digestive enzymes
in vitro such as α-amylase and α-glucosidase (Mai et al.
2007; Apostolidis and Lee 2010), where hydroxylation of
flavonoids increases α-glucosidase inhibition. Furthermore,
it has been demonstrated that polyphenols such as
phlorotannin can interact with and precipitate proteins (Stern
et al. 1996). There are some limitations to the use of polyphe-
nols therapeutically as they degrade in UV light and at high
temperatures (Volf et al. 2014) potentially reducing their util-
ity as a food additive targeted at reducing pancreatic lipase
activity. Moreover, polyphenols are a non-fiber compound
and would not be able to bind undigested fats, therefore if
included in the diet may cause steatorrhea, similar to Orlistat
(Hsu et al. 2006).
The TPC of the seaweeds released during in vitro digestion
differed significantly between species. F. vesiculosus showed
the highest polyphenol release ranging from 29 to 61 mg g−1
through the in vitro digestion while A. nodosum was the low-
est at 11–35 mg g−1. Apostolidis et al. (2010) found that the
TPC of A. nodosum extracted with water at 80 °C for 30 min
was in the range 22–35 mg g−1 when investigating the sea-
sonal variation in TPC of A. nodosum harvested in Canada
(Apostolidis and Lee 2010). This is similar to the range found
in A. nodosum in this study. Wang et al. (2009) also reported
that the TPC of F. vesiculosus was higher than that of
A. nodosum (Wang et al. 2009).
There are limitations to this assessment of TPC, as the
stability of the polyphenols through the in vitro digestion is
unknown, and the Folin–Ciocalteu method most likely over-
estimates TPC because it also reacts with other hydroxyl con-
taining species (this is why polyphenols could not be assessed
in the presence of pancreatin). The seaweed F. vesiculosus had
the highest level of TPC at 70 min and the lowest IC50 values
for both homogenate and supernatant. P. canaliculata was the
next most potent inhibitor for both homogenate and superna-
tant and had the second highest TPC (Table 4). The homoge-
nate and ethanol supernatant extracts would be expected to be
rich in polyphenols, but the sodium carbonate extract and
ethanol pellet extraction would not.
While these data suggests that extracts rich in polyphenols
tend to be more potent inhibitors of lipase, further investiga-
tion is required to characterise and purify the polyphenols
present in the seaweed samples to confirm a causal relation-
ship. While the polyphenol rich extracts F. vesiculosus and
P. canaliculata tend to inhibit more potently, there is no linear
correlation between levels of polyphenols and levels of lipase
inhibition. It is therefore possible that the type of polyphenols
is also important, and the specific composition of the polyphe-
nols in F. vesiculosus is important in their inhibitory effects.
It is clear that with the presence of fucoidans, alginates,
polyphenols, and other components, seaweeds are comprised
of multiple bioactive agents which may act alone or in concert
to be potent inhibitors of lipase activity with potential thera-
peutic applications. Characterising and isolating the various
components of the seaweeds would be useful for further study,
while nutritional component analysis would provide informa-
tion for suitability as a functional food ingredient.
Evidence from the lipase activity assay and gut model sug-
gest that the crude seaweed homogenate and ethanol superna-
tant extract for these particular seaweeds are potential pancre-
atic lipase inhibitors which have the potential to control die-
tary fat digestion. Furthermore, the physicochemical nature of
the homogenate when in solution in the gut lumen provides
capacity for binding of dietary fatty acids, a potential second-
ary mechanism for the prevention of fat digestion. Previous
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studies indicate that psyllium mucilloid dietary fiber products
may reduce gastrointestinal side effects when taken concom-
itantly with Orlistat (Cavaliere et al. 2001). The seaweed ho-
mogenate may offer similar protection, alongside the
polyphenol-rich supernatant. Human intervention studies
would be required to evidence weight loss, confirm accept-
ability, and record any side effects of seaweed-enriched food-
stuffs; however, this may be promising area for further study.
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